$AMRS
The Illuminator – One of the big announcements made this year was the launch of the Illuminator. For some time, AMRS has worked with Biossance to come up with the product. Now, the product is on the market and will likely generate strong profits ahead.
DOE Agreement – Another big agreement announced earlier in the year was an agreement with the United States Department of Energy. According to this agreement, the company is working with the DOE to produce a key ingredient in biofuels. That ingredient is known as cellulose-derived farnesene.
Gevaudan – Another big agreement that was announced this year is an agreement between AMRS and Givaudan - a leader in flavors and fragrances around the world. According to this agreement, the two will be working together to develop proprietary fragrance ingredients.
Biogen – Another big agreement took place early on in the year. This agreement was with Biogen. Ultimately, the two companies are working to use advanced microbe engineering technology to evaluate and develop multiple host microorganisms. The ultimate goal is that Amyris and Biogen will use these microorganisms as alternatives to mammalian cell lines for the production of therapeutic recombinant proteins.
Extended Agreement – Finally, AMRS announced in late September that the company has reached an extended agreement with a global nutraceuticals leader. The extended agreement includes the addition of a new nutraceutical target, a credit line of up to $25 million with a 5-year maturity, and an option for a $5 million strategic investment.
News 
Market Data 
Discover 
